1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Functional Dyspepsia - Epidemiology Forecast to 2030

Functional Dyspepsia - Epidemiology Forecast to 2030

  • August 2021
  • 64 pages
  • ID: 6129793
  • Format: PDF
  • Delve Insight


Table of Contents

‘Functional Dyspepsia – Epidemiology Forecast—2030’ report delivers an in-depth understanding of Functional Dyspepsia, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Functional Dyspepsia Disease Understanding
Dyspepsia is a constellation of symptoms predominantly in the gastroduodenal region of the upper gastrointestinal tract. Functional dyspepsia is defined as at least one month of epigastric discomfort without evidence of organic disease found during an upper endoscopy, and it accounts for 70% of dyspepsia. The Rome diagnostic criteria classified into two non-exclusive subtypes: postprandial distress syndrome (PDS), and epigastric pain syndrome (EPS).

The key symptoms of are early satiety, postprandial fullness, epigastric pain, or burning. Other symptoms may include nausea, vomiting, loss of appetite. Though is a prevalent functional gastrointestinal disorder (FGID), it is often difficult to diagnose as it is caused by heterogeneous factors. The major pathogenesis of includes infectious and post-infectious changes in the gut, abnormal gastric motility, visceral hypersensitivity, and psychosocial and genetic factors.

Functional Dyspepsia Epidemiology
The Functional Dyspepsia epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool, trends, and assumptions.

Key Findings
The total incident cases of Functional Dyspepsia patients are increasing by 7MM during the study period, i.e., 2018–2030.
The disease epidemiology covered in the report provides historical as well as forecasted Functional Dyspepsia symptoms epidemiology segmented as the Prevalence of Functional Dyspepsia, Type-specific cases of Functional Dyspepsia, Age-specific Cases of Functional Dyspepsia, and Gender-specific cases of Functional Dyspepsia. The report includes the incident scenario of Functional Dyspepsia symptoms in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.

Country-wise Functional Dyspepsia Epidemiology
The epidemiology segment also provides the Functional Dyspepsia epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
The Prevalent cases of Functional Dyspepsia associated in 7MM countries were 48.959.8 in 2020.
• As per the estimates, the United States has the largest prevalent population of Functional Dyspepsia (FD).
• Among the EU5 countries, Italy had the highest prevalent cases of Functional Dyspepsia (FD), followed by Germany. On the other hand, Spain had the lowest prevalent cases with 3,027.4 cases in 2020.

Scope of the Report
• The Functional Dyspepsia report covers a detailed overview explaining its causes, symptoms, and classification, pathophysiology, diagnosis, and treatment patterns.
• The Functional Dyspepsia Epidemiology Report and Model provide an overview of Functional Dyspepsia ’s risk factors and global trends in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
• The report provides insight into Functional Dyspepsia ’s a historical and forecasted patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of Functional Dyspepsia.
• The report provides the segmentation of the Functional Dyspepsia epidemiology by the prevalence of in 7MM.
• The report provides the Functional Dyspepsia epidemiology segmentation by Type-specific cases of in 7MM.
• The report provides the Functional Dyspepsia epidemiology segmentation by Age-specific Cases of in 7MM.
• The report provides the Functional Dyspepsia epidemiology segmentation by Gender-specific cases of in 7MM.

Report Highlights

• 10-year Forecast of Functional Dyspepsia epidemiology
• 7MM Coverage
• Prevalence of Functional Dyspepsia
• Type-specific cases of Functional Dyspepsia
• Age-specific Cases of Functional Dyspepsia
• Gender-specific Cases of Functional Dyspepsia

KOL Views
We interview KOLs, and SMEs’ opinions through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered
• What will be the growth opportunities in the 7MM for the patient population about Functional Dyspepsia?
• What are the key findings of the Functional Dyspepsia epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2018–2030)?
• What would be the total number of Functional Dyspepsia patients across the 7MM during the forecast period (2018–2030)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2018–2030)?
• At what CAGR the patient population is expected to grow by 7MM during the forecast period (2018–2030)?
• What are the disease risk, burden, and unmet needs of Functional Dyspepsia?
• What are the currently available treatments for Functional Dyspepsia?

Reasons to buy
The Functional Dyspepsia epidemiology report will allow the user to -
• Develop business strategies by understanding the trends shaping and driving the global Functional Dyspepsia market.
• Quantify patient populations in the global Functional Dyspepsia market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Functional Dyspepsia therapeutics in each of the markets covered.
• Understand the magnitude of the Functional Dyspepsia population by its prevalence.
• Understand the magnitude of the Functional Dyspepsia population by its Type-specific cases.
• Understand the magnitude of the Functional Dyspepsia population by its Age-specific cases.
• Understand the magnitude of the Insomnia population by its Gender-specific cases.
• The Functional Dyspepsia epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
• The Functional Dyspepsia Epidemiology Model developed is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Key Assessments
• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2018–2030
Functional Dyspepsia has been reported to affect an estimated 21% of the general population, with prevalence varying from 29.5% when using broad historical definitions (i.e., any upper gastrointestinal symptoms, including reflux) to 7.6% when using the symptoms defined by the Rome III committee (i.e., epigastric pain or burning [or both], postprandial fullness or early satiety [or both]). More than 70% of people with dyspepsia undergoing endoscopy will have no identifiable organic pathology to account for their symptoms and will be diagnosed with functional dyspepsia, which can be further sub-grouped into epigastric pain syndrome (EPS), postprandial distress syndrome (PDS), and the overlapping variant.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Gastrointestinal Bleeding Treatment Devices Global Market Report 2021: COVID-19 Growth And Change

  • $ 5000
  • October 2021
  • 175 pages

Major players in the gastrointestinal bleeding treatment devices market are CONMED, Boston Scientific Corporation, US Medical Innovations, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin ...

  • World
  • United States
  • Digestive System Disorder
  • Industry analysis


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on